4.4 Article

The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

Yoon K. Loke et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)

Article Endocrinology & Metabolism

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

S. Benvenuti et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)

Article Medicine, General & Internal

Diabetes drug pioglitazone (Actos): risk of fracture

Reza Heidarpour Meymeh et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)

Article Endocrinology & Metabolism

Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy

Carolina A. M. Kulak et al.

ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)